Welcome to the e-CCO Library!

P290 Long-term disease outcome of ulcerative colitis (UC) in South Ostrobothnia, Finland with a follow-up time of 25 years
Year: 2020
Source:

ECCO'20 Vienna

Authors:

K. Kontola1, P. Oksanen2, H. Huhtala3, H. Tunturi-Hihnala1, A. Jussila4

Created: Thursday, 30 January 2020, 10:12 AM
P290: Compliance to vaccination guidelines in patients with immune-mediated inflammatory diseases: a cross-sectional, single-centre study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Coenen*1, D. Bertrand2, T. Vanhoutvin3, P. Verschueren4, P. De Haes3, P. De Munter5, S. Vermeire1, M. Ferrante1

Created: Friday, 22 February 2019, 9:41 AM
P290: Determination of small-bowel patency in Crohn’s disease - a prospective study
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Santos1*, M. Silva1, H. Cardoso1, R. Cunha2, A. Peixoto1, R. Gaspar1, S. Lopes1, G. Macedo1

Created: Thursday, 21 February 2019, 9:14 AM
P290: Development of an artificial intelligence model using stool pictures for predicting endoscopic mucosal inflammation in patients with Ulcerative Colitis; KASID multicenter study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kim, E.S.(1)*;Lee, J.W.(1);Kim, S.K.(1);Lee, H.S.(1);Lee, Y.J.(2);Kim, J.(2);Kim, K.O.(3);Jang, B.I.(3);Kim, E.Y.(4);Jung, Y.J.(1);Park, S.K.(5);Park, D.I.(5);Woo, D.(6);Jeong, S.(6);
Created: Friday, 14 July 2023, 11:05 AM
P290: Evaluation of patients with retained patency capsule
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Silva M., Cardoso H., Peixoto A., Marques M., Nunes A.C.-R., Lopes S., Magro F., Macedo G.

Created: Wednesday, 20 February 2019, 10:36 AM
P290: Impact of concomitant 5-aminosalicylic acid therapy on vedolizumab efficacy and safety in Inflammatory Bowel Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Ungaro, R.(1);Kadali, H.(2);Zhang, W.(3);Adsul, S.(4);Reinisch, W.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P290: Pre-operative anti-glycan antibodies and anti-glycan antibodies developing after pouch surgery in patients with ulcerative colitis correlate with pouch complications: a prospective longitudinal case series
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

I. Goren*1, L. Yahav2, H. Tulchinsky3, 4, I. Dotan4, 5

Created: Friday, 22 February 2019, 9:49 AM
P290: Therapeutic requirements in patients with Ulcerative Proctitis. Is it necessary immunosuppressive therapy in these patients?
Year: 2022
Source: ECCO'22
Authors: Ferreiro Iglesias, R.(1);Porto Silva, M.S.(1);Marín, S.(2);Casanova, M.J.(3);Mañosa, M.(4);González-Muñoza, C.(5);de Francisco, R.(6);Caballol, B.(7);Arias, L.(8);Piqueras, M.(9);Zabana , Y.(10);Rivero, M.(11);Calvet, X.(12);Mesonero, F.(13);Varela Trastoy, P.(14);Busta Nistal, R.(15);Gomez Perosanz, R.(16);Vega, P.(17);Gonzalez Vivo, M.(18);Iborra, M.(19);Jimenez Marquez, L.(20);Madero, L.(21);Rodríguez-Lago, I.(22);Rodriguez Gonzalez , M.(23);Vera, I.(24);Ponferrada Diaz, A.(25);Vela, M.(26);Torrealba, L.(27);Van Domselaar, M.(28);Iglesias , E.(2);P. Gisbert, J.(3);Calafat, M.(4);García-Planella, E.(5);Perez-Martinez, I.(6);Ricart, E.(7);Sicilia , B.(8);Mena, R.(9);Nieto, L.(1);Domenech, E.(4);Barreiro-de Acosta, M.(1);
Created: Friday, 11 February 2022, 3:52 PM
P291 Diagnostic utility of the neutrophil-platelet rate (NeuPla) as a marker of activity in patients with ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.K. Yamamoto-Furusho MD- PhD1, E.A. Mendieta-Escalante2

Created: Thursday, 30 January 2020, 10:12 AM
P291: Can the prognostic index be a predicting factor for mortality and morbidity in intestinal resection of patients with ulcerative colitis?
Year: 2018
Source: ECCO '18 Vienna
Authors:

T. Chohno*, M. Uchino, T. Minagawa, R. Kuwahara, Y. Horio, H. Sasaki, T. Bando, Y. Takesue, H. Ikeuchi

Created: Thursday, 21 February 2019, 9:14 AM
P291: Effect of the preconception steroid-free remission period on disease activity during pregnancy and birth outcomes in women with Ulcerative Colitis: a retrospective cohort study
Year: 2022
Source: ECCO'22
Authors: Ikeda, A.(1);Kunisaki, R.(1);Aoki, S.(2);Yaguchi, K.(1);Asami, S.(1);Furusawa, K.(1);Atsusaka, R.(1);Azuma, D.(1);Tsunoda, S.(1);Fujii, K.(1);Nishida, D.(1);Madarame, A.(1);Nishio, M.(1);Ogashiwa, T.(1);Nakamori, Y.(1);Fuse, M.(1);Daibo, S.(1);Araki, K.(1);Kimura, H.(1);Suzuki, R.(3);Go, H.(4);Saigusa, Y.(4);Maeda, S.(5);
Created: Friday, 11 February 2022, 3:52 PM
P291: Improvements in access to IBD care following the implementation of a novel tiered triage model
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

L. Wilson*1, D. Loomes1,2

Created: Friday, 22 February 2019, 9:41 AM
P291: Long term outcomes of children with ulcerative colitis after acute severe colitis: a multicenter study from the GETAID pédiatrique group
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Pigneur, B.(1)*;Cochet, M.(1);Delphine , L.(2);Coopman, S.(2);Raphael , E.(3);Thierry, L.(3);Claire , D.(4);Stéphanie , W.(5);Rémi , D.L.(6);Georges , D.(7);Valérie, B.(8);Anne, B.(9);Christine, M.(10);Jerome, V.(10);Frank, R.(11);Julie, L.(12);
Created: Friday, 14 July 2023, 11:05 AM
P291: Pharmacokinetics, safety, and tolerability of etrasimod (APD334) in subjects with mild, moderate, or severe hepatic impairment: a single-dose, open-label, parallel-group study
Year: 2021
Source: ECCO'21 Virtual
Authors: Lee, C.(1);Tang, Y.(1);Schroeder, C.(1);Zhang, J.(1);Nguyen-Cleary, T.(1);Mullin, S.(1);Ma, M.(1); Lyon, N.(1);Grundy, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P291: Proteinase 3-antineutrophil cytoplasmic antibodies (PR3-ANCA) would be a predictive biomarker for the clinical course of ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sono M., Yoshino T., Yazumi S.

Created: Wednesday, 20 February 2019, 10:36 AM
P291: Sacroiliitis is under-recognised in inflammatory bowel disease and is associated with previous arthritis and inflammatory Crohn’s phenotype
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

O. Kelly*1, N. Li1, J. Chan2, R. Inman2, M. Silverberg1

Created: Friday, 22 February 2019, 9:49 AM
P292 Inflammatory bowel disease and their implications in Roma ethnicity: A preliminary study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

B. Castro1, M.J. García García1, M. Pascual1, J.L. Fernández-Forcelledo2, J. Crespo1, M. Rivero1

Created: Thursday, 30 January 2020, 10:12 AM
P292: Association of golimumab trough concentrations during maintenance with endoscopic and histologic remission in patients with ulcerative colitis.
Year: 2022
Source: ECCO'22
Authors: Taxonera Samso, C.(1);Fernández-Aceñero, M.J.(2);Olivares, D.(1);Calvo, M.(3);Casis, B.(4);Bermejo, F.(5);López Serrano, P.(6);Iborra, M.(7);Mesonero, F.(8);Boscá Watts, M.(9);Díaz del Arco, C.(2);Vera, I.(3);Olivares, S.(4);Alba, C.(1);
Created: Friday, 11 February 2022, 3:52 PM
P292: Complications in elderly-onset Inflammatory Bowel Diseases – A population-based study from the epidemiological database of the Israeli IBD Research Nucleus (Epi-IIRN)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Ben Hur, D.(1)*;Lebedenko, B.(2);Issaschar, G.(3);Moshe, R.(3);Lujan, R.(4);Focht, G.(4);Loewenberg Weisband, Y.(5);Kariv, R.(6);Ledderman, N.(7);Matz, E.(8);Dotan, I.(9);Turner, D.(4);Pinto, G.(3);Waterman , M.(1);
Created: Friday, 14 July 2023, 11:05 AM
P292: Development of a predictive model for the diagnosis of Crohn’s disease when ileocolonoscopy is insufficient: a multicentre study
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

P. Boal Carvalho*1, M. Marques2, B. Rosa1, H. Cardoso2, F. Machado3, G. Macedo2, J. Cotter1, 4, 5

Created: Friday, 22 February 2019, 9:49 AM